Nutraplus India Ltd

Nutraplus India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nutraplus India Ltd

₹ 2.10 5.00%
13 Dec 2021
nutraplusindia.com
About

Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.

[ add key points ]
Website
  • Market Cap ₹ 7.16 Cr.
  • Current Price ₹ 2.10
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -1.53
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
13.76 0.01 0.00 0.00 0.01 0.05 0.04 0.00 0.00 0.00 0.00 0.00 0.00
43.19 0.05 0.07 0.11 0.49 0.02 0.00 0.01 3.71 0.01 0.08 0.01 0.12
Operating Profit -29.43 -0.04 -0.07 -0.11 -0.48 0.03 0.04 -0.01 -3.71 -0.01 -0.08 -0.01 -0.12
OPM % -213.88% -400.00% -4,800.00% 60.00% 100.00%
0.07 0.03 0.00 0.03 -23.42 0.56 0.05 0.00 0.01 0.00 0.00 0.00 0.00
Interest 1.43 0.07 0.15 0.06 0.18 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.03
Depreciation 1.20 1.20 1.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -31.99 -1.28 -1.39 -0.14 -24.08 0.59 0.09 -0.01 -3.70 -0.01 -0.11 -0.01 -0.15
Tax % -0.06% 0.00% 0.00% 0.00% -3.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-31.98 -1.28 -1.39 -0.14 -23.23 0.59 0.09 -0.01 -3.70 -0.01 -0.11 -0.01 -0.15
EPS in Rs -9.38 -0.38 -0.41 -0.04 -6.81 0.17 0.03 -0.00 -1.09 -0.00 -0.03 -0.00 -0.04
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
44.68 39.52 61.56 65.00 77.51 91.05 109.14 139.55 106.67 0.02 0.10 -0.06
38.34 32.17 51.37 61.79 65.37 92.78 99.83 126.89 142.44 0.38 3.75 0.07
Operating Profit 6.34 7.35 10.19 3.21 12.14 -1.73 9.31 12.66 -35.77 -0.36 -3.65 -0.13
OPM % 14.19% 18.60% 16.55% 4.94% 15.66% -1.90% 8.53% 9.07% -33.53% -1,800.00% -3,650.00%
0.11 0.20 0.10 -2.94 1.48 0.99 0.12 1.58 0.08 -23.36 0.62 0.00
Interest 1.55 2.40 3.57 4.52 4.86 5.01 4.67 6.85 7.43 0.80 0.00 0.03
Depreciation 0.63 1.30 1.61 1.40 1.72 2.21 3.88 4.03 4.70 0.00 0.00 0.00
Profit before tax 4.27 3.85 5.11 -5.65 7.04 -7.96 0.88 3.36 -47.82 -24.52 -3.03 -0.16
Tax % 30.44% 36.88% 38.75% -28.14% -12.64% -21.36% 84.09% 34.82% 0.00% 0.00% 0.00% 0.00%
2.97 2.43 3.13 -4.06 7.93 -6.26 0.14 2.19 -47.83 -24.52 -3.03 -0.16
EPS in Rs 2.61 1.98 2.41 -1.66 2.85 -1.84 0.04 0.64 -14.03 -7.19 -0.89 -0.05
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 7.99% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -160%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 26%
TTM: 95%
Stock Price CAGR
10 Years: -29%
5 Years: -20%
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital 5.20 5.60 5.90 11.16 12.67 17.05 17.05 17.05 17.05 17.05 17.05 17.05
Reserves 7.61 11.22 14.35 36.01 50.22 50.17 50.19 52.40 4.57 -19.10 -22.13 -22.28
14.90 21.71 31.55 40.29 72.05 65.77 73.38 74.93 75.88 1.75 1.75 1.76
15.87 15.91 23.44 26.60 30.66 37.27 31.21 25.32 39.37 34.99 12.28 8.72
Total Liabilities 43.58 54.44 75.24 114.06 165.60 170.26 171.83 169.70 136.87 34.69 8.95 5.25
19.29 27.46 35.67 22.95 32.89 38.64 72.31 82.44 81.19 0.00 0.00 0.00
CWIP 0.02 0.86 1.04 13.42 37.53 48.27 21.59 17.26 12.67 0.12 0.00 0.00
Investments 1.80 0.00 0.05 4.20 4.15 4.16 4.15 4.15 0.15 0.15 0.15 0.15
22.47 26.12 38.48 73.49 91.03 79.19 73.78 65.85 42.86 34.42 8.80 5.10
Total Assets 43.58 54.44 75.24 114.06 165.60 170.26 171.83 169.70 136.87 34.69 8.95 5.25

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
7.57 3.50 3.98 -16.49 -9.61 19.66 6.69 12.36 9.07 -14.25 -0.15 0.02
-10.59 -8.50 -10.82 -5.10 -34.42 -18.59 -10.70 -9.74 -2.69 93.77 0.12 0.00
3.12 5.10 6.80 31.53 35.54 -1.91 4.00 -2.66 -7.57 -80.25 0.00 -0.03
Net Cash Flow 0.10 0.10 -0.04 9.94 -8.48 -0.84 -0.01 -0.03 -1.18 -0.73 -0.03 -0.01

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 98.52 97.25 87.57 75.13 119.80 104.79 83.71 42.97 9.48 19,710.00 1,898.00 -2,676.67
Inventory Days 82.18 165.59 169.68 134.40 181.03 113.18 110.73 124.02 89.78 363.97 0.00
Days Payable 150.75 186.82 168.01 186.44 189.62 177.37 132.71 75.89 35.11 878.67
Cash Conversion Cycle 29.96 76.02 89.25 23.09 111.21 40.60 61.73 91.10 64.15 19,710.00 1,383.31 -2,676.67
Working Capital Days 40.44 74.63 83.66 173.68 244.26 126.16 113.47 81.84 98.27 447,855.00 0.00 -22,386.67
ROCE % 25.14% 18.72% 19.22% 2.89% 9.65% -2.85% 4.06% 8.78% -33.35% -0.56%

Shareholding Pattern

Numbers in percentages

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07%
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
59.91% 59.91% 59.91% 59.91% 59.91% 59.90% 59.90% 59.90% 59.91% 59.90% 59.91% 59.91%
No. of Shareholders 8,0887,8787,8427,8167,8287,8437,8117,8057,8177,7507,7247,943

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Annual reports

Credit ratings

Concalls

  • Sep 2016
    Transcript
    Notes
    PPT